Lucknow
Recently, India’s first anti-diabetic ayurvedic drug “BGR -34”, which is designed for type 2 Diabetes mellitus, has been launched by Council for Scientific and Industrial Research (CSIR). The BGR- 34 is jointly developed by National Botanical Research Institute (NBRI) and Central Institute of Medicinal and Aromatic Plants (CIMAP). It helps in controlling blood sugar and limits the harmful effects and toxicity of other drugs. The headquarters of CIMAP is located at Lucknow, Uttar Pradesh.